ANVS Annovis Bio, Inc.
$1.12▼ -5.88%
Healthcare
Other
After hours
$1.15▲ +2.71%
Sep 11, 7:43 PM ET
Volume 1.89M
Avg Volume (10D) 1.62M
Key Metrics & Fundamentals
Market Cap
$47.72M
P/E Ratio
–
Div Yield
–%
52W Range
1.11 - 5.50
% vs 50 MA
-35.30%
% vs 200 MA
-53.60%
RSI-14
20.4
MACD Histogram
-0.0700
Beta (1Y vs SPY)
1.80
Free Cash Flow
-$21.91M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$15.36M
COGS
–
Operating Exp
$14.38M
Operating Income
-$14.38M
EBIT
-$14.38M
Pretax Income
-$14.82M
Net Income
-$14.82M
EPS (Diluted)
-0.40
Price & Volume History
Loading chart…
Recent News
Annovis Bio (ANVS) Loses 26.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks · Sep 8, 2026 1:35 PM
Annovis Bio Targets March 2027 Alzheimer’s Readout, Prepares Rolling NDA
MarketBeat · Sep 3, 2026 2:01 AM
Annovis to Host Corporate Update Webinar on September 2, 2026
GlobeNewswire · Aug 25, 2026 12:00 PM
Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results
GlobeNewswire · Aug 14, 2026 12:00 PM
The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight
PR Newswire · Aug 6, 2026 2:31 PM
Annovis Bio Enrolls Over 850 Patients for Its Next Alzheimer's Disease Trial
NYSE · Jul 7, 2026 2:51 PM
Annovis Bio Completes Patient Enrollment for Phase 3 Study of Buntanetap in Alzheimer's Disease
MT Newswires · Jul 7, 2026 11:18 AM
Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease
GlobeNewswire · Jul 7, 2026 11:00 AM
Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer
GlobeNewswire · Jul 1, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ANVS's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.